Abstract:Background: Regeneration of tooth-supporting structures destroyed by periodontitis is a major goal of periodontal therapy. Periodontal tissue engineering utilizing growth and amelogenin-like factors (GAFs) applies advances in materials science and biology to regenerate alveolar bone, periodontal ligament, and cementum. Amelogenin-like factors (e.g., enamel matrix derivative [EMD]) and growth factors (e.g., platelet-derived growth factor [PDGF] and bone morphogenetic proteins [BMPs, also considered morphogens]) have demonstrated pleotrophic effects on the stimulation of several key events required for tissue regeneration including DNA synthesis, chemotaxis, differentiation, and matrix synthesis. Rationale: GAFs have been used for the treatment of periodontal disease as shown in preclinical and clinical studies. This systematic review evaluates the evidence to support the utilization of EMD and growth factors (GFs) for periodontal repair and regeneration associated with natural teeth. Focused question: In patients with periodontal osseous defects, what is the effect of GAFs compared with controls on clinical, radiographic, histologic, adverse, and patient-centered outcomes? Search protocol: Two investigators searched MEDLINE, pre-MEDLINE, and the Cochrane Oral Health Group trials register for clinical and preclinical studies published in English. Hand searches were performed on the International Journal of Periodontics and Restorative Dentistry, Journal of Clinical Periodontology, Journal of Dental Research, Journal of Periodontology, and Journal of Periodontal Research. Searches were performed for articles published through April 2002. In addition, investigators contacted manufacturers of GAF products for related unpublished data and studies in progress. Inclusion criteria: Randomized controlled clinical trials (RCTs), cohort studies, case-control studies, case reports, and preclinical (animal) randomized controlled investigations that included a cohort population diagnosed with periodontal disease and presenting data on intrabony/interproximal defects and/or furcation defects were screened. Exclusion criteria: In vitro studies or those that did not include quantifiable data with respect to clinical or bone measures were not included. Data collection and analysis: Meta-analyses were performed for studies that fulfilled the eligibility criteria for the following continuous variables: clinical attachment level (CAL), probing depth (PD), or bone level (radiographic, re-entry, or histologic). Heterogeneity was assessed to determine whether the differences among therapies were due to systematic confounding factors (as noted in study quality assessments). Main results: 1. Eight studies, representing 7 RCTs and 1 quasi-experimental study, representing a total population of 511 subjects were analyzed with respect to EMD. 2. The majority of the remaining papers had a low evidence rating. 3. Most reports were case studies or case series without controls. 4. There were insufficient data to conduct a meta-analysis on the effect of growth factors used in periodontal repair around teeth. Reviewers' conclusions: 1. There is evidence supporting the use of EMD for periodontal osseous defects to improve CAL and reduce PD, although long-term benefits have not been established. 2. EMD has demonstrated notable consistency among the studies investigated in terms of superiority to controls (in general compared to open flap debridement [OFD]). 3. EMD appears to be safe for single and multiple administrations in terms of lack of elicitation of antibody responses or other local/systemic inflammatory events. 4. Preclinical and initial clinical data for growth factors appear promising but are insufficient to draw definitive conclusions at this time.

Efficacy Of Recombinant Human Pdgf And Fgf-2 For Regenerative Dentistry

Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficiency as adjunctive to the GTR procedure in periodontal intrabony defects

Regeneration Potential of Decellularized Periodontal Ligament Cell Sheets Combined with 15-Deoxy-δ12,14-prostaglandin J2 Nanoparticles in a Rat Periodontal Defect

Periodontal Regeneration by Gene Therapy

Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications

Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures

Recombinant Human Derived Growth and Differentiating Factors in treatment of periodontal intrabony defects: Systematic review and network meta‐analysis

Predictive factors of periodontal regeneration outcomes using rhFGF‐2: A case–control study

A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects

The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing

Use of PRP, PRF and CGF in Periodontal Regeneration and Facial Rejuvenation—A Narrative Review

The potential application of concentrated growth factor in pulp regeneration: an in vitro and in vivo study

Future Prospects for Periodontal Bioengineering Using Growth Factors.

Effect of Concentrated Growth Factors on Function and Wnt3a Expression of Human Periodontal Ligament Cells in Vitro

Biologic Agents for Periodontal Regeneration and Implant Site Development.

Growth and amelogenin-like factors in periodontal wound healing. A systematic review

Periodontal regeneration using platelet-rich fibrin. Furcation defects: A systematic review with meta-analysis

Optimizing esthetic zone periodontal regeneration in a 1-2-wall infrabony defect using recombinant human platelet-derived growth factor BB and β-tricalcium phosphate: A case report

New insights into and novel applications of release technology for periodontal reconstructive therapies

Efficacy of concentrated growth factor (CGF) in the surgical treatment of oral diseases: a systematic review and meta-analysis

Fabricating periodontal tissue engineering compound by gene modified gingival fibroblasts and acellular dermal matrix